-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
(3'R)-Ezetimibe is a cholesterol-lowering drug that is used to treat high cholesterol levels in the blood.
It is a synthetic drug that is derived from a natural compound called monacolin K, which is found in red yeast rice.
The drug works by inhibiting an enzyme called HMG-CoA reductase, which is involved in the production of cholesterol in the liver.
There are several synthetic routes that can be used to prepare (3'R)-ezetimibe, including chemical synthesis and biotechnological methods.
In chemical synthesis, the drug is typically prepared by a series of chemical reactions that involve the formation of various intermediates.
These reactions can be carried out using a variety of chemical reagents and conditions, depending on the specific synthetic route.
One of the most common methods for the synthesis of (3'R)-ezetimibe involves a multi-step process that involves the preparation of several key intermediates.
The process typically begins with the synthesis of a compound known as 2,2-dimethyl-1,3-oxazolidin-3-one, which is then converted into a compound known as 2,2-dimethyl-1,3-oxazolidin-4-one.
This compound is then reduced to form a compound known as 2,2-dimethyl-1,3-oxazolidin-4-ol, which is a key intermediate in the synthesis of (3'R)-ezetimibe.
The next step in the synthesis of (3'R)-ezetimibe involves the conversion of 2,2-dimethyl-1,3-oxazolidin-4-ol into a compound known as 3-chloro-2,2-dimethyl-1,3-oxazolidin-4-one.
This compound can then be treated with a variety of reagents to form a variety of other intermediates, which can ultimately be converted into (3'R)-ezetimibe.
In addition to chemical synthesis, (3'R)-ezetimibe can also be prepared by biotechnological methods.
One such method involves the use of microorganisms such as bacteria or yeast to produce the drug.
This process typically involves the expression of the gene that encodes (3'R)-ezetimibe in the microorganism, which is then used to produce the drug using fermentation techniques.
Overall, the synthetic routes to (3'R)-ezetimibe are complex and require the use of various chemical reagents and conditions.
However, the drug is widely used to treat high cholesterol levels in the blood, and its synthesis is an important area of research in the chemical industry.